[ad_1]
This procedure is the first step in approving this preparation for use in the block area.
“The EEA has launched an ongoing review of Sputnik V, a COVID-19 vaccine developed by the Gamalea National Center for Epidemiology and Microbiology,” the Amsterdam-based EVA said in a statement.
Russia, for its part, has said that if Sputnik V is approved in the European Union, it could be supplied with enough vaccines starting at June 50 million. Europeans vaccinated.
“The approval of the EEA will allow the Sputnik V vaccine to be administered to 50 million people in the EU from June 2021,” said Kirill Dmitryev, director of the Russian Direct Investment Fund (RTIF), which finances the Sputnik program. V.
Russia certified the drug in August last year, which has yet to conduct large-scale clinical trials, leading many experts to question the drug.
However, the authoritative medical journal The Lancet subsequently published research showing that the vaccine is safe and 91.6 percent effective.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
